PMS33 COST EFFECTIVENESS OF ABATACEPT IN COMPARISON WITH OTHER BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS PATIENTS WHO HAVE FAILED TO METHOTREXATE BASED TREATMENT AT ESSALUD IN 2010
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.718
https://www.valueinhealthjournal.com/article/S1098-3015(11)00857-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
178
First Page :
A129
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00857-6&doi=10.1016/j.jval.2011.02.718